2025 by the Numbers – EGPAF

2025 by the Numbers – EGPAF

In 2025, we continued our transformational work. This year was marked by disruptions, but we remained committed to our mission. Across Sub-Saharan Africa, EGPAF staff worked tirelessly to provide prevention, testing, care, and treatment services to children and their families.   607,512 pregnant women were supported with prevention of mother-to-child transmission services 310,873 children (0-14 years of age) at risk…

Read More
Top Media Moments of 2025  

Top Media Moments of 2025  

Top Media Moments   Who will tell the story?   Throughout 2025, EGPAF worked closely with journalists and media houses across the world to tell the story of the foreign aid cuts and the fight against pediatric HIV. Our experts, leaders, and clients acted as expert sources in a period of vast misinformation and confusion.   As we reflect on the year,…

Read More
Combination therapy shows promise to treat a rare, catastrophic pediatric brain cancer

Combination therapy shows promise to treat a rare, catastrophic pediatric brain cancer

St. Jude Children’s Research Hospital scientists identified a promising combination approach to treat a rare, but catastrophic pediatric brain cancer called atypical teratoid rhabdoid tumor (ATRT). Reactivating and maintaining p53, a protein responsible for tumor suppression, using the drugs idasantulin and selinexor, respectively, was well-tolerated, reduced tumor burden and increased survival in a laboratory model….

Read More